Oshika, Tetsuro http://orcid.org/0000-0002-9071-7018
Kiuchi, Gaku
Article History
Received: 13 September 2023
Accepted: 26 September 2023
First Online: 12 October 2023
Declarations
:
: Dr. Tetsuro Oshika received compensation as a consultant from Alcon, Johnson & Johnson Vision, Santen Pharmaceutical, HOYA, Topcon, and Logic and Design. He receives research support from Santen Pharmaceutical, Tomey, Alcon, Senju Pharmaceutical, Johnson & Johnson Vision, HOYA, KOWA Pharmaceutical, Otsuka Pharmaceutical, Novartis, Topcon, Tomey, and Chugai Pharmaceutical. Dr. Gaku Kikuchi does not have any conflict of interest.
: The study was conducted in adherence to the tenets of the Declaration of Helsinki, and the institutional review board of Tsukuba University Hospital approved the study protocol (R04-162, December 2022). The institutional review board of Tsukuba University Hospital committee waived the need for patient informed consent for the use of their medical record data, in line with the regulations of the Japanese Guidelines for Epidemiologic Study issued by the Japanese Government. Due to the observational nature of the study, clinical trial registration was not mandated.